Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Von Hippel-Lindau Tumor Suppressor, E3 Ubiquitin Protein Ligase (VHL) Peptide

VHL Reactivity: Human, Rat Host: Synthetic BP
Catalog No. ABIN2709908
  • Target See all VHL products
    VHL (Von Hippel-Lindau Tumor Suppressor, E3 Ubiquitin Protein Ligase (VHL))
    Origin
    Human, Rat
    Source
    • 4
    Synthetic
    Application
    Blocking Peptide (BP)
    Characteristics
    The peptide is used to block Anti-Von Hippel Lindau Antibody reactivity.
  • Application Notes
    Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Storage
    -20 °C
    Storage Comment
    Shipped at 4°C. Store at -20°C for one year.
    Expiry Date
    12 months
  • Target
    VHL (Von Hippel-Lindau Tumor Suppressor, E3 Ubiquitin Protein Ligase (VHL))
    Synonyms
    HRCA1 Peptide, RCA1 Peptide, VHL1 Peptide, pVHL Peptide, BcDNA:RH61560 Peptide, CG13221 Peptide, DVhl Peptide, Dmel\\CG13221 Peptide, Dvhl Peptide, VHL Peptide, d-VHL Peptide, d-vhl Peptide, dVHL Peptide, dmVHL Peptide, vhl Peptide, rca1 Peptide, vhl1 Peptide, hrca1 Peptide, zgc:158722 Peptide, Vhlh Peptide, von Hippel-Lindau tumor suppressor Peptide, von Hippel-Lindau Peptide, von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase Peptide, von Hippel-Lindau disease tumor suppressor Peptide, VHL Peptide, Vhl Peptide, vhl Peptide, CpipJ_CPIJ009992 Peptide
    Background
    Von Hippel-Lindau disease tumor suppressor, Protein G7, pVHL
    Gene ID
    7428, 24874
    UniProt
    P40337, Q64259
You are here:
Support